Institutional & Family Asset Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $34.3K | Sell |
166
-4
| -2% | -$826 | 0.01% | 281 |
|
|
2024
Q1 | $46.1K | Sell |
170
-9
| -5% | -$2.44K | 0.01% | 241 |
|
|
2023
Q4 | $42.3K | Sell |
179
-2
| -1% | -$473 | 0.01% | 250 |
|
|
2023
Q3 | $35.5K | Hold |
181
| – | – | 0.01% | 245 |
|
|
2023
Q2 | $38.1K | Buy |
181
+22
| +14% | +$4.63K | 0.01% | 246 |
|
|
2023
Q1 | $32.1K | Sell |
159
-1
| -0.6% | -$202 | 0.01% | 253 |
|
|
2022
Q4 | $34.9K | Buy |
160
+7
| +5% | +$1.53K | 0.01% | 251 |
|
|
2022
Q3 | $30K | Hold |
153
| – | – | 0.01% | 265 |
|
|
2022
Q2 | $33K | Buy |
153
+28
| +22% | +$6.04K | 0.01% | 259 |
|
|
2022
Q1 | $35K | Buy |
125
+19
| +18% | +$5.32K | 0.01% | 284 |
|
|
2021
Q4 | $40K | Buy |
+106
| New | +$40K | 0.01% | 286 |
|
|
2019
Q4 | – | Sell |
-14
| Closed | -$2K | – | 857 |
|
|
2019
Q3 | $2K | Sell |
14
-15
| -52% | -$2.14K | ﹤0.01% | 680 |
|
|
2019
Q2 | $4K | Buy |
29
+24
| +480% | +$3.31K | ﹤0.01% | 615 |
|
|
2019
Q1 | $1K | Buy |
+5
| New | +$1K | ﹤0.01% | 775 |
|